Physician profile
Frank Gerardi
NPI 1356450571
$1,006.37
in general payments reported to CMS, 2019-2025
10 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2022: $69.45 · 2023: $171 · 2024: $322 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $300.00 | 2024-2025 | Rezdiffra |
| Braintree Laboratories, INC. | $172.00 | 2024 | Sutab, Suflave |
| Dova Pharmaceuticals | $131.03 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Zeposia |
| Capsovision, INC. | $107.73 | 2025 | Capsocam Plus |
| Ironwood Pharmaceuticals, INC | $63.59 | 2022-2023 | Linzess |
| Medtronic USA, INC. | $36.43 | 2019 | |
| Celgene Corporation | $26.25 | 2022 | |
| Abbvie INC. | $25.40 | 2023 | |
| Novo Nordisk INC | $18.94 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Gerardi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.